It is estimated that 10 000 people per year die following trauma in England and Wales and 30—40% do so due to uncontrolled haemorrhage. By the time the patient reaches hospital, coagulopathy is often already installed and needs to be corrected promptly to prevent further haemorrhage and allow effective treatment of injuries. The coagulopathy is multifactorial with the leading causes being acidosis, hypothermia and massive transfusion. Early recognition of the condition is imperative using standard coagulation testing; however, there are limitations in this setting. Newer methods of testing `global haemostasis' using thromboelastography are becoming more popular but need further validation. Treatment of coagulopathy requires a multidisciplinary approach. Blood product transfusion remains the cornerstone of management but newer pharmacological agents such as recombinant factor VIIa are increasingly being used. Here we review the pathogenesis, investigation and management of the coagulopathy of trauma.
Azu MC, McCormack JE, Huang EC, Lee TK, Shapiro MJ2007. Venous thromboembolic events in hospitalized trauma patients . Am Surg73: 1228-31.
2.
Bauza G., Hirsch E., Burke P., Quillen K.2007. Low-dose recombinant activated factor VII in massively transfused trauma patients with coagulopathy. Transfusion47: 749-51.
3.
Bickell WH, Wall Jr MJ, Pepe PE, Martin RR, Ginger VF, Allen MK, Mattox KL1994. Immediate versus delayed fluid resuscitation for hypotensive patients with penetrating torso injuries. N Engl J Med331: 1105-09.
4.
Boffard KD, Riou B., Warren B., Choong PI, Rizoli S., Rossaint R., Axelsen M., Kluger Y.2005. Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, double-blind clinical trials. J Trauma59: 8-15.
5.
Brohi K., Cohen MJ, Davenport RA2007a. Acute coagulopathy of trauma: mechanism, identification and effect. Curr Opin Crit Care13: 680-85.
6.
Brohi K., Cohen MJ, Ganter MT, Matthay MA, Mackersie RC, Pittet JF2007b. Acute traumatic coagulopathy: initiated by hypoperfusion: modulated through the protein C pathway? Ann Surg245: 812-18.
7.
Brohi K., Singh J., Heron M., Coats T.2003. Acute traumatic coagulopathy. J Trauma54: 1127-30.
8.
Brummel-Ziedins K., Whelihan MF, Ziedins EG, Mann KG2006. The resuscitative fluid you choose may potentiate bleeding . J Trauma61: 1350-58.
9.
CDC: Web-Based Injury Statistics Query and Reporting System (WISQARS).2002. US Department of Health and Human Services, CDC, National Centre for Injury Prevention and Control.
10.
Coats T., Roberts I., Shakur H.2004. Antifibrinolytic drugs for acute traumatic injury. Cochrane Database Syst Rev, CD004896.
Cosgriff N., Moore EE, Sauaia A., Kenny-Moynihan M., Burch JM, Galloway B.1997. Predicting life-threatening coagulopathy in the massively transfused trauma patient: hypothermia and acidoses revisited. J Trauma42: 857-61.
13.
Counts RB, Haisch C., Simon TL, Maxwell NG, Heimbach DM, Carrico CJ1979. Hemostasis in massively transfused trauma patients. Ann Surg190: 91-99.
14.
de Jonge E., Levi M.2001. Effects of different plasma substitutes on blood coagulation: a comparative review. Crit Care Med29: 1261-67.
15.
De Waele JJ, Van CS, Hoste E., Benoit D., Colardyn F.2003. The use of the activated clotting time for monitoring heparin therapy in critically ill patients. Intensive Care Med29: 325-28.
16.
Durham RM, Moran JJ, Mazuski JE, Shapiro MJ, Baue AE, Flint LM2003. Multiple organ failure in trauma patients. J Trauma55: 608-16.
17.
Dutton RP, Carson JL2006. Indications for early red blood cell transfusion. J Trauma60: S35-S40.
18.
Dutton RP, McCunn M., Hyder M., D'Angelo M., O'Connor J., Hess JR, Scalea TM2004. Factor VIIa for correction of traumatic coagulopathy. J Trauma57: 709-18.
19.
Engstrom M., Schott U., Romner B., Reinstrup P.2006. Acidosis impairs the coagulation: A thromboelastographic study. J Trauma61: 624-28.
20.
Fakhry SM, Sheldon GF1994. Massive transfusion in the surgical patient. In: Jeffries LC, Brecher ME eds. Massive Transfusion American Association of Blood Banks, Bethesda, MD, USA.
21.
Fenger-Eriksen C., nker-Moller E., Heslop J., Ingerslev J., Sorensen B.2005. Thrombelastographic whole blood clot formation after ex vivo addition of plasma substitutes: improvements of the induced coagulopathy with fibrinogen concentrate. Br J Anaesth94: 324-29.
22.
Ferrara A., MacArthur JD, Wright HK, Modlin IM, McMillen MA1990. Hypothermia and acidosis worsen coagulopathy in the patient requiring massive transfusion. Am J Surg160: 515-18.
23.
Franklin GA, Boaz PW, Spain DA, Lukan JK, Carrillo EH, Richardson JD2000. Prehospital hypotension as a valid indicator of trauma team activation. J Trauma48: 1034-37.
24.
Fries D., Innerhofer P., Klingler A., Berresheim U., Mittermayr M., Calatzis A., Schobersberger W.2002. The effect of the combined administration of colloids and lactated Ringer's solution on the coagulation system: an in vitro study using thrombelastograph coagulation analysis (ROTEG). Anesth Analg94: 1280-87.
25.
Fries D., Krismer A., Klingler A., Streif W., Klima G., Wenzel V., Haas T., Innerhofer P.2005. Effect of fibrinogen on reversal of dilutional coagulopathy: a porcine model. Br J Anaesth95: 172-77.
26.
Gabriel DA, Li X., Monroe III DM, Roberts HR2004. Recombinant human factor VIIa (rFVIIa) can activate factor FIX on activated platelets. J Thromb Haemost2: 1816-22.
27.
Ganter MT, Brohi K., Cohen MJ, Shaffer LA, Walsh MC, Stahl GL, Pittet JF2007. Role of the alternative pathway in the early complement activation following major trauma. Shock28: 29-34.
28.
Geerts WH, Code KI, Jay RM, Chen E., Szalai JP1994. A prospective study of venous thromboembolism after major trauma. N Engl J Med331: 1601-06.
29.
Geerts WH, Pineo GF, Heit JA, Bergqvist D., Lassen MR, Colwell CW, Ray JG2004. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest126: 338S-400S.
30.
Gentilello LM, Pierson DJ2001. Trauma critical care. Am J Respir Crit Care Med163: 604-07.
31.
Gilabert J., Estelles A., Aznar J., Galbis M.1985. Abruptio placentae and disseminated intravascular coagulation . Acta Obstet Gynecol Scand64: 35-9. Goodnight SH, Hathaway WE2001. Haemostasis and Thrombosis, 2nd edn, Vol. 3, McGraw-Hill , Medical publishing division, USA.
32.
Hardy JF, de MP, Samama CM2006. Massive transfusion and coagulopathy: pathophysiology and implications for clinical management. Can J Anaesth53: S40-S58.
33.
Hartert H.1948. Blutgeinnung studien mit der thromboelastographie, einen neuen untersuchingsverfahren. Kiln Wochenschrift26: 577-83.
34.
Hebert PC, Wells G., Blajchman MA, Marshall J., Martin C., Pagliarello G., Tweeddale M., Schweitzer I., Yetisir E.1999. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med340: 409-17.
35.
Heckbert SR, Vedder NB, Hoffman W., Winn RK, Hudson LD, Jurkovich GJ, Copass MK, Harlan JM, Rice CL, Maier RV1998. Outcome after hemorrhagic shock in trauma patients. J Trauma45: 545-49.
36.
Hellem AJ, Borchgrevink CF, Ames SB1961. The role of red cells in haemostasis: the relation between haematocrit, bleeding time and platelet adhesiveness. Br J Haematol7: 42-50.
37.
Henry DA, Moxey AJ, Carless PA, O'Connell D., McClelland B., Henderson KM, Sly K., Laupacis A., Fergusson D.2001. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev, CD001886.
38.
Hensler T., Heinemann B., Sauerland S., Lefering R., Bouillon B., Andermahr J., Neugebauer EA2003. Immunologic alterations associated with high blood transfusion volume after multiple injury: effects on plasmatic cytokine and cytokine receptor concentrations. Shock20: 497-502.
39.
Hess JR2007. Blood and coagulation support in trauma care. Hematology Am Soc Hematol Educ Program2007: 187-91.
Hirshberg A., Dugas M., Banez EI, Scott BG, Wall Jr MJ, Mattox KL2003. Minimizing dilutional coagulopathy in exsanguinating hemorrhage: a computer simulation. J Trauma54: 454-63.
42.
Ho AM, Dion PW, Cheng CA, Karmakar MK, Cheng G., Peng Z., Ng YW2005. A mathematical model for fresh frozen plasma transfusion strategies during major trauma resuscitation with ongoing hemorrhage. Can J Surg48: 470-78.
43.
Hoffman M., Monroe III DM2001. A cell-based model of hemostasis. Thromb Haemost85: 958-65.
44.
Holcomb JB2004. Methods for improved hemorrhage control. Critical Care8: S57-S60.
45.
Hoyt DB, Bulger EM, Knudson MM, Morris J., Ierardi R., Sugerman HJ, Shackford SR, Landercasper J., Winchell RJ, Jurkovich G.1994. Death in the operating room: an analysis of a multicenter experience. J Trauma37: 426-32.
46.
Hulka F., Mullins RJ, Frank EH1996. Blunt brain injury activates the coagulation process. Arch.Surg131: 923-27.
47.
Iselin BM, Willimann PF, Seifert B., Casutt M., Bombeli T., Zalunardo MP, Pasch T., Spahn DR2001. Isolated reduction of haematocrit does not compromise in vitro blood coagulation. Br J Anaesth87: 246-49.
48.
Iwata H., Kaibara M.2002. Activation of factor IX by erythrocyte membranes causes intrinsic coagulation. Blood Coagul Fibrinolysis13: 489-96.
49.
Johnston TD, Chen Y., Reed RL1994. Functional equivalence of hypothermia to specific clotting factor deficiencies. J Trauma37: 413-17.
50.
Kaibara M., Iwata H., Ujiie H., Himeno R., Kaibara M.2005. Rheological analyses of coagulation of blood from different individuals with special reference to procoagulant activity of erythrocytes . Blood Coagul Fibrinolysis16: 355-63.
51.
Kang YG, Martin DJ, Marquez J., Lewis JH, Bontempo FA, Shaw Jr BW, Starzl TE, Winter PM1985. Intraoperative changes in blood coagulation and thrombelastographic monitoring in liver transplantation. Anesth Analg64: 888-96.
52.
Kaufmann CR, Dwyer KM, Crews JD, Dols SJ, Trask AL1997. Usefulness of thrombelastography in assessment of trauma patient coagulation. J Trauma42: 716-20.
53.
Kauvar DS, Lefering R., Wade CE2006. Impact of hemorrhage on trauma outcome: an overview of epidemiology, clinical presentations, and therapeutic considerations. J Trauma60: S3-11.
54.
Kauvar DS, Wade CE2005. The epidemiology and modern management of traumatic hemorrhage: US and international perspectives. Crit Care9(Suppl 5): S1-S9.
55.
Kermode JC, Zheng Q., Milner EP1999. Marked temperature dependence of the platelet calcium signal induced by human von Willebrand factor. Blood94: 199-207.
56.
Ketchum L., Hess JR, Hiippala S.2006. Indications for early fresh frozen plasma, cryoprecipitate, and platelet transfusion in trauma. J Trauma60: S51-S58.
57.
Klitgaard T., Palacios R., Boffard KD, Iau PT, Warren B., Rizoli S., Rossaint R., Kluger Y., Riou B.2006. Pharmacokinetics of recombinant activated factor VII in trauma patients with severe bleeding. Crit Care10: R104.
58.
Kooistra T., Schrauwen Y., Arts J., Emeis JJ1994. Regulation of endothelial cell t-PA synthesis and release . Int J Hematol59: 233-55.
59.
Leslie SD, Toy PT1991. Laboratory hemostatic abnormalities in massively transfused patients given red blood cells and crystalloid. Am J Clin Pathol96: 770-73.
60.
Levi M.2007. Disseminated intravascular coagulation. Crit Care Med35: 2191-95.
MacLeod J., Lynn M., McKenney MG, Jeroukhimov I., Cohn SM2004. Predictors of mortality in trauma patients. Am Surg70: 805-10.
64.
MacLeod JB, Lynn M., McKenney MG, Cohn SM, Murtha M.2003. Early coagulopathy predicts mortality in trauma. J Trauma55: 39-44.
65.
Malone DL, Dunne J., Tracy JK, Putnam AT, Scalea TM, Napolitano LM2003. Blood transfusion, independent of shock severity, is associated with worse outcome in trauma. J Trauma54: 898-905.
66.
Mangano DT, Tudor IC, Dietzel C.2006. The risk associated with aprotinin in cardiac surgery . N Engl J Med354: 353-65.
67.
Manley G., Knudson MM, Morabito D., Damron S., Erickson V., Pitts L.2001. Hypotension, hypoxia, and head injury: frequency, duration, and consequences. Arch Surg136: 1118-23.
68.
Marietta M., Facchini L., Girardis M., Luppi M., Torelli G.2006. More on: Platelet count and the use of recombinant factor VIIa for the treatment of bleeding complications after hematopoietic stem cell transplantation. J Thromb Haemost4: 288.
69.
Martini WZ, Chinkes DL, Pusateri AE, Holcomb JB, Yu YM, Zhang XJ, Wolfe RR2005. Acute changes in fibrinogen metabolism and coagulation after hemorrhage in pigs. Am J Physiol Endocrinol Metab289: E930-E934.
70.
Martini WZ, Dubick MA, Wade CE, Holcomb JB2007. Evaluation of tris-hydroxymethylaminomethane on reversing coagulation abnormalities caused by acidosis in pigs. Crit Care Med35: 1568-74.
71.
McIntyre L., Hebert PC, Wells G., Fergusson D., Marshall J., Yetisir E., Blajchman MJ2004. Is a restrictive transfusion strategy safe for resuscitated and critically ill trauma patients? J Trauma57: 563-68.
72.
McNulty SE, Torjman M., Grodecki W., Marr A., Schieren H.1995. A comparison of four bedside methods of hemoglobin assessment during cardiac surgery. Anesth Analg81: 1197-202.
73.
Meng ZH, Wolberg AS, Monroe III DM, Hoffman M.2003. The effect of temperature and pH on the activity of factor VIIa: implications for the efficacy of high-dose factor VIIa in hypothermic and acidotic patients. J Trauma55: 886-91.
74.
Michelson AD, MacGregor H., Barnard MR, Kestin AS, Rohrer MJ, Valeri CR1994. Reversible inhibition of human platelet activation by hypothermia in vivo and in vitro. Thromb Haemost71: 633-40.
75.
Miller RD, Robbins TO, Tong MJ, Barton SL1971. Coagulation defects associated with massive blood transfusions . Ann Surg174: 794-801.
76.
Mollison PL, Engelfeit CP, Contreras M.1997. Transfusion in oligaemia. Blood transfusion in clinical medicineBlackwell Science: Oxford : p. 47.
77.
Moore FA, Sauaia A., Moore EE, Haenel JB, Burch JM, Lezotte DC1996. Postinjury multiple organ failure: a bimodal phenomenon . J Trauma40: 501-10.
78.
Norfolk DR, Ancliffe PJ, Contreras M., Hunt BJ, Machin SJ, Murphy WG, Williamson LM 1998. Consensus Conference on Platelet Transfusion, Royal College of Physicians of Edinburgh, 27-28 November 1997. Synopsis of background papers. Br J Haematol101: 609-17.
79.
O'Shaughnessy DF, Atterbury C., Bolton MP, Murphy M., Thomas D., Yates S., Williamson LM2004c. Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant. Br J Haematol126: 11-28.
80.
O'Shaughnessy DF, Atterbury C., Bolton MP, Murphy M., Thomas D., Yates S., Williamson LM2004a. Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant. Br J Haematol126: 11-28.
81.
O'Shaughnessy DF, Atterbury C., Bolton MP, Murphy M., Thomas D., Yates S., Williamson LM2004b. Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant. Br J Haematol126: 11-28.
82.
Oung CM, Li MS, Shum-Tim D., Chiu RC, Hinchey EJ1993. In vivo study of bleeding time and arterial hemorrhage in hypothermic versus normothermic animals. J Trauma35: 251-54.
83.
Peyrou V., Lormeau JC, Herault JP, Gaich C., Pfliegger AM, Herbert JM1999. Contribution of erythrocytes to thrombin generation in whole blood. Thromb Haemost81: 400-06.
84.
Pina-Cabral JM, Ribeiro-da-Silva A., meida-Dias A.1985. Platelet sequestration during hypothermia in dogs treated with sulphinpyrazone and ticlopidine- reversibility accelerated after intra-abdominal rewarming. Thromb Haemost54: 838-41.
85.
Plurad D., Martin M., Green D., Salim A., Inaba K., Belzberg H., Demetriades D., Rhee P.2007. The decreasing incidence of late posttraumatic acute respiratory distress syndrome: the potential role of lung protective ventilation and conservative transfusion practice. J Trauma63: 1-7.
86.
Practice parameter for the use of fresh-frozen plasma, cryoprecipitate, and platelets. Fresh-frozen plasma, cryoprecipitate, and platelets administration practice guidelines development task force of the college of american pathologists . 1994. JAMA271: 777-81.
87.
Quaknine-Orlando B., Samama CM, Riou B., Bonnin P., Guillosson JJ, Beaumont JL, Coriat P.1999. Role of the hematocrit in a rabbit model of arterial thrombosis and bleeding. Anesthesiology90: 1454-61.
88.
Reed RL, Johnson TD, Hudson JD, Fischer RP1992. The disparity between hypothermic coagulopathy and clotting studies. J Trauma33: 465-70.
89.
Rizoli SB, Boffard KD, Riou B., Warren B., Iau P., Kluger Y., Rossaint R., Tillinger M.2006. Recombinant activated factor VII as an adjunctive therapy for bleeding control in severe trauma patients with coagulopathy: subgroup analysis from two randomized trials. Crit Care10: R178.
90.
Roche AM, James MF, Grocott MP, Mythen MG2006. Just scratching the surface: varied coagulation effects of polymer containers on TEG variables. Eur J Anaesthesiol23: 45-9.
91.
Rossaint R., Cerny V., Coats TJ, Duranteau J., Fernandez-Mondejar E., Gordini G., Stahel PF, Hunt BJ, Neugebauer E., Spahn DR2006. Key issues in advanced bleeding care in trauma. Shock26: 322-31. Royston D., von KS2001. Reduced haemostatic factor transfusion using heparinase-modified thrombelastography during cardiopulmonary bypass. Br J Anaesth86: 575-78.
92.
Rugeri L., Levrat A., David JS, Delecroix E., Floccard B., Gros A., Allaouchiche B., Negrier C.2007. Diagnosis of early coagulation abnormalities in trauma patients by rotation thrombelastography. J Thromb Haemost5: 289-95.
93.
Salooja N., Perry DJ2001. Thrombelastography. Blood Coagul.Fibrinolysis12: 327-37.
94.
Samama CM, Djoudi R., Lecompte T., Nathan-Denizot N., Schved JF2005. Perioperative platelet transfusion: recommendations of the Agence Francaise de Securite Sanitaire des Produits de Sante (AFSSaPS) 2003. Can J Anaesth52: 30-7.
95.
Santos MT, Valles J., Marcus AJ, Safier LB, Broekman MJ, Islam N., Ullman HL, Eiroa AM, Aznar J.1991. Enhancement of platelet reactivity and modulation of eicosanoid production by intact erythrocytes. A new approach to platelet activation and recruitment. J Clin Invest87: 571-80.
96.
Sauaia A., Moore FA, Moore EE, Lezotte DC1996. Early risk factors for postinjury multiple organ failure . World J Surg20: 392-400.
97.
Sauaia A., Moore FA, Moore EE, Moser KS, Brennan R., Read RA, Pons PT1995a. Epidemiology of Trauma Deaths - A Reassessment. Journal of Trauma-Injury Infection and Critical Care38: 185-93.
98.
Sauaia A., Moore FA, Moore EE, Moser KS, Brennan R., Read RA, Pons PT1995b. Epidemiology of Trauma Deaths - A Reassessment. Journal of Trauma-Injury Infection and Critical Care38: 185-93.
99.
Schmied H., Kurz A., Sessler DI, Kozek S., Reiter A.1996. Mild hypothermia increases blood loss and transfusion requirements during total hip arthroplasty. Lancet347: 289-92.
100.
Schneiderman J., Adar R., Savion N.1991. Changes in plasmatic tissue-type plasminogen activator and plasminogen activator inhibitor activity during acute arterial occlusion associated with severe ischemia. Thromb Res62: 401-08.
101.
Schols SE, van der Meijden PE, van OR, Curvers J., Heemskerk JW, van Pampus EC2008. Increased thrombin generation and fibrinogen level after therapeutic plasma transfusion: Relation to bleeding. Thromb Haemost99: 64-70.
102.
Schreiber MA, Differding J., Thorborg P., Mayberry JC, Mullins RJ2005. Hypercoagulability is most prevalent early after injury and in female patients. J Trauma58: 475-80.
103.
Shima M., Tanaka I., Sawamoto Y., Kanehiro H., Matsuo N., Nishimura A., Giddings JC, Yoshioka A.1997. Successful treatment of two brothers with congenital afibrinogenemia for splenic rupture using heat- and solvent detergent-treated fibrinogen concentrates . J Pediatr Hematol Oncol19: 462-65.
104.
Spahn DR, Cerny V., Coats TJ, Duranteau J., Fernandez-Mondejar E., Gordini G., Stahel PF, Hunt BJ, Komadina R., Neugebauer E., Ozier Y., Riddez L., Schultz A., Vincent JL, Rossaint R.2007. Management of bleeding following major trauma: a European guideline. Crit Care11: R17.
105.
Stainsby D., MacLennan S., Hamilton PJ2000a. Management of massive blood loss: a template guideline . Br J Anaesth85: 487-91.
106.
Stainsby D., MacLennan S., Hamilton PJ2000b. Management of massive blood loss: a template guideline . Br J Anaesth85: 487-91.
107.
Stainsby D., MacLennan S., Thomas D., Isaac J., Hamilton PJ2006. Guidelines on the management of massive blood loss. Br J Haematol135: 634-41.
108.
Stanworth SJ2007. The Evidence-Based Use of FFP and Cryoprecipitate for Abnormalities of Coagulation Tests and Clinical Coagulopathy. Hematology Am Soc Hematol Educ Program179-86.
109.
Stanworth SJ, Brunskill SJ, Hyde CJ, McClelland DB, Murphy MF2004. Is fresh frozen plasma clinically effective? A systematic review of randomized controlled trials. Br J Haematol126: 139-52.
110.
Taylor Jr FB, Toh CH, Hoots WK, Wada H., Levi M.2001. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost86: 1327-30.
111.
Trauma Audit and Research Network (TARN), http://www.tarn.ac.uk. 2008.
112.
Valeri CR, Cassidy G., Pivacek LE, Ragno G., Lieberthal W., Crowley JP, Khuri SF, Loscalzo J.2001. Anemia-induced increase in the bleeding time: implications for treatment of nonsurgical blood loss. Transfusion41: 977-83.
Valeri CR, Khabbaz K., Khuri SF, Marquardt C., Ragno G., Feingold H., Gray AD, Axford T.1992. Effect of skin temperature on platelet function in patients undergoing extracorporeal bypass. J Thorac Cardiovasc Surg104: 108-16.
115.
Velmahos GC, Kern J., Chan LS, Oder D., Murray JA, Shekelle P.2000. Prevention of venous thromboembolism after injury: an evidence-based report-part II: analysis of risk factors and evaluation of the role of vena caval filters. J Trauma49: 140-44.
116.
Vig S., Chitolie A., Bevan DH, Halliday A., Dormandy J.2001. Thromboelastography: a reliable test? Blood Coagul Fibrinolysis12: 555-61.
117.
Vincent JL, Rossaint R., Riou B., Ozier Y., Zideman D., Spahn DR2006. Recommendations on the use of recombinant activated factor VII as an adjunctive treatment for massive bleeding-a European perspective . Crit Care10: R120.
Wolberg AS, Meng ZH, Monroe Dmiii, Hoffman M.2004. A systematic evaluation of the effect of temperature on coagulation enzyme activity and platelet function. J Trauma56: 1221-28.
120.
Yoshihara H., Yamamoto T., Mihara H.1985. Changes in coagulation and fibrinolysis occurring in dogs during hypothermia. Thromb Res37: 503-12.
121.
Yuan S., Ferrell C., Chandler WL2007. Comparing the prothrombin time INR versus the APTT to evaluate the coagulopathy of acute trauma. Thromb Res120: 29-37.
122.
Zambruni A., Thalheimer U., Leandro G., Perry D., Burroughs AK2004. Thromboelastography with citrated blood: comparability with native blood, stability of citrate storage and effect of repeated sampling . Blood Coagul Fibrinolysis15: 103-07.
